PER

1.35%

7.5¢ percheron therapeutics limited

For General Information, page-3012

First 3012 Last

Share
Profile

Follow
schueym99

1,717 Posts.

118

19/09/23

09:40

Post #: 69911063
Share

Originally posted by dalts66: ↑

I cant see anything wrong with your reasoning. If another party finds another use for ATL1102 now, they can claim the IP for that use.

Having said that, ANP have really narrowed that available field, by focusing on biomarkers and method of use against them. They have honed in on how this drug works, identified the target proteins and interaction, and have IP covering that. This relates to multiple diseases from AML, MS and lots of other inflammation disease.

So for another company to lock in asthma, for example, they would need to prove that the drug targeting the biomarkers ANP hold the IP for isnt the reason it works for Asthma. This is why I think the IP from mid 2022 is so important.

Any company could ask ANP for a licence to use the drug against asthma, targeting the biomarkers ANP hold the IP for.

You have highlighted an important thing here Boomy, and you have been all over this point for a few years. As you have said, its of great interest now, as it directly effects the ANP revenue potential, in a good way. Without IP over the nuts and bolts of how ATL1102 works, it would be open market for any drug development company to use in any indication not already named and protected.

Expand

this helps my understanding and may actually be the reason why boomy and itsa are both correct.

no actual patent over ATL1102 but the methods of use are so tight to bio markers that it may protect against others from using the same types of approaches on other indications if they are effectively the same bio markers for that indication.

interesting.

ANP Price at posting: 6.6¢ Sentiment: Buy Disclosure: Held
8 Upvote

1 Great analysis

Reply

Top Stories

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

Nine's staff strike as Paris Olympic coverage begins

ASX Market Open: ASX200 to rise for Friday session | July 26

MND

Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?

MIN

MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned

RHK

Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit

IGO

IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity

TRP

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

NVA

Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter

HRZ

Horizon firms up ore reserve for Boorara ahead of FY25 Q1 development decision

There are more pages in this discussion • 515 more messages in this thread...

First 3012 Last

Add PER (ASX) to my watchlist

(20min delay)
Last 7.5¢		Change 0.001(1.35%)		Mkt cap ! $67.61M

Open	High	Low	Value	Volume
7.7¢	7.8¢	7.4¢	$24.63K	325.4K

Buyers (Bids)

No.	Vol.	Price($)
2	142779	7.3¢

Sellers (Offers)

Price($)	Vol.	No.
7.5¢	8181	1

View Market Depth

No.	Vol.	Price($)
2	142779	0.073
2	147362	0.072
2	310000	0.071
4	34299	0.070
2	28980	0.069

Price($)	Vol.	No.
0.075	8181	1
0.078	125476	3
0.079	175123	2
0.080	287231	3
0.081	125000	2

Last trade - 16.10pm 26/07/2024 (20 minute delay)

PER (ASX) Chart

For General Information, page-3012

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

Nine's staff strike as Paris Olympic coverage begins

ASX Market Open: ASX200 to rise for Friday session | July 26

Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?

MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned

Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit

IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter

Horizon firms up ore reserve for Boorara ahead of FY25 Q1 development decision

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

For General Information, page-3012

Top Stories

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

Nine's staff strike as Paris Olympic coverage begins

ASX Market Open: ASX200 to rise for Friday session | July 26

Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?

MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned

Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit

IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter

Horizon firms up ore reserve for Boorara ahead of FY25 Q1 development decision

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News